See also this year's filing and all EDGAR filings for this company.
PDF Report 0001001316_2017_TG_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001001316, TG Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 50,864,144 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 799,391 |
| 2 | PropertyPlantAndEquipmentNet | 328,148 |
| 3 | remainder_Assets | 2,789,864 |
| 4 | LiabilitiesCurrent | 16,878,440 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,035,305 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,926,550 |
| 9 | ResearchAndDevelopmentExpense | 77,671,287 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,017,272 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 54,781,547 |
| 1 | Liabilities | 18,913,745 |
| 2 | Expenses | 87,597,837 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 35,867,802 |
| 5 | NetIncome | -86,580,565 |
| 6 | ComprehensiveNetIncome | -86,580,565 |
| 7 | BaseVar | 81,155,200 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.228 |
| 9 | EconomicCapitalRatio | 1.40 |